These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6297678)

  • 41. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molindone: higher doses needed to block pergolide-induced elevation of serum corticosterone than to elevate dopamine metabolites in brain.
    Fuller RW; Snoddy HD
    Life Sci; 1983 Dec; 33(23):2357-61. PubMed ID: 6645804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for dopamine as a transmitter in dorsal hippocampus.
    Ishikawa K; Ott T; McGaugh JL
    Brain Res; 1982 Jan; 232(1):222-6. PubMed ID: 7055704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Haloperidol-induced increases in rat amygdaloid dopamine metabolism: evidence for independence from postsynaptic feedback mechanisms.
    Essig EC; Kilpatrick IC
    Neurosci Lett; 1991 Feb; 123(2):261-4. PubMed ID: 2027541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The dopaminergic amacrine system and its response to light stimulation in rats with inherited retinal dystrophy.
    Frucht Y; Melamed E
    Exp Eye Res; 1984 Apr; 38(4):391-8. PubMed ID: 6723813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased effect of apomorphine on homovanillic acid in rats terminated from chronic haloperidol.
    Smith RC; Narasimhachari N; Davis JM
    J Neural Transm; 1978; 42(2):159-62. PubMed ID: 650206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
    Contreras SA; Maas JW; Seleshi E; Bowden CL
    Biol Psychiatry; 1988 Nov; 24(7):818-22. PubMed ID: 3067756
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of haloperidol and probenecid on plasma and CSF dopamine metabolites in the rhesus monkey (Macacca mulatta).
    Bacopoulos NG; Heninger GR; Roth RH
    Life Sci; 1978 Oct; 23(17-18):1805-12. PubMed ID: 102888
    [No Abstract]   [Full Text] [Related]  

  • 49. Circadian rhythmicity in dopamine content of mammalian retina: role of the photoreceptors.
    Doyle SE; McIvor WE; Menaker M
    J Neurochem; 2002 Oct; 83(1):211-9. PubMed ID: 12358745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drugs and the frog retina. Effect of dopaminergic agents on the pigment screening of light- and dark-adapted frogs.
    Kemali M; Milici N; Kemali D
    Neuropharmacology; 1984 Mar; 23(3):381-5. PubMed ID: 6610134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retinal amacrine cell system tyrosine hydroxylase: the development of responsiveness to light and neuroleptic drugs.
    Cohen J; Neff NH
    Brain Res; 1982 Jan; 255(1):160-3. PubMed ID: 6120027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conditioning and the delayed onset of a haloperidol-induced behavioral effect.
    Carey RJ
    Biol Psychiatry; 1987 Mar; 22(3):269-77. PubMed ID: 3814679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinal dopamine and its metabolite contents in zitter rats and spontaneously epileptic rats.
    Kobayashi K; Kawashima K; Kawashima Y; Yamamura T; Kuse H; Asano Y; Kawai Y; Hori M; Okaniwa A; Serikawa T
    Jikken Dobutsu; 1993 Apr; 42(2):249-50. PubMed ID: 8519304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral dopamine, apomorphine and oral activity in the neonatal pig.
    Fry JP; Sharman DF; Stephens DB
    J Vet Pharmacol Ther; 1981 Sep; 4(3):193-207. PubMed ID: 7349334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retina-dependent activation by apomorphine of metabolic activity in the superficial layer of the superior colliculus.
    McCulloch J; Savaki HE; McCulloch MC; Sokoloff L
    Science; 1980 Jan; 207(4428):313-5. PubMed ID: 7350662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous dopamine and cyclic events in the fish retina, I: HPLC assay of total content, release, and metabolic turnover during different light/dark cycles.
    Kolbinger W; Kohler K; Oetting H; Weiler R
    Vis Neurosci; 1990 Aug; 5(2):143-9. PubMed ID: 2278941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended exposure to continuous low intensity light abolishes the photosensitivity of retinal dopamine neurons.
    Morgan WW; Kamp CW
    Life Sci; 1983 Oct; 33(14):1419-26. PubMed ID: 6621247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of potency of metoclopramide's metabolites in various dopaminergic models.
    Stanley M; Wazer D; Virgilio J; Kuhn CM; Benson DI; Meyerson LR
    Pharmacol Biochem Behav; 1983 Feb; 18(2):263-6. PubMed ID: 6682229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exposure to light accelerates the formation of dopamine from exogenous L-dopa in the rat retina.
    Xu JA; Hadjiconstantinou M; Neff NH
    J Ocul Pharmacol; 1985; 1(2):177-81. PubMed ID: 3880074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AJ76 and UH232 as potential agents for diagnosing early-stage Parkinson's disease.
    Zhou J; Li J; Papaneri AB; Cui G
    Neuropharmacology; 2023 Mar; 226():109397. PubMed ID: 36623805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.